Cypre's blog to discuss the latest movements in science.
Cypre's CEO, Kolin Hribar, PhD, will be taking meetings with partners to advance the next generation of cancer therapeutics. Reach out to schedule a meeting.
Partner with Cypre to generate translational insights using our 3D tumor microenvironment organoid platform. From targeting the tumor or stroma, to modulating the immune system, we’re built for collaboration.
